Bradykinin B 2 Receptor Modulates Renal Prostaglandin E 2 and Nitric Oxide
|
|
- Margery Ray
- 5 years ago
- Views:
Transcription
1 (Hypertension. 1997;29: ) 1997 American Heart Association, Inc. Bradykinin B 2 Receptor Modulates Renal Prostaglandin E 2 and Nitric Oxide Helmy M. Siragy; Ayad A. Jaffa; Harry S. Margolius the Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville, and the Departments of Pharmacology and Medicine, Medical University of South Carolina and Ralph A. Johnson VA Medical Center, Charleston. Correspondence to Helmy M. Siragy, MD, Department of Medicine, Box 482, University of Virginia Health Sciences Center, Charlottesville, VA ABSTRACT Bradykinin and lys-bradykinin generated intrarenally appear to be important renal paracrine hormones. However, the renal effects of endogenously generated bradykinin are still not clearly defined. In this study, we measured acute changes in renal excretory and hemodynamic functions and renal cortical interstitial fluid levels of bradykinin, prostaglandin E 2, and cgmp in response to an acute intrarenal arterial infusion of the bradykinin B 2 receptor antagonist Hoe 140 (icatibant), cyclooxygenase inhibitor indomethacin, or nitric oxide synthase inhibitor N G -monomethyl-l-arginine (L-NMMA) given individually or combined in uninephrectomized, conscious dogs (n=10) in low sodium balance. Icatibant caused a significant decrease in urine flow, urinary sodium excretion, and renal plasma flow rate (each P<.001). Glomerular filtration rate did not change during icatibant administration. Icatibant produced an unexpected large increase in renal interstitial fluid bradykinin (P<.0001) while decreasing renal interstitial fluid prostaglandin E 2 and cgmp (each P<.001). Both indomethacin and L-NMMA when given individually caused significant antidiuresis and antinatriuresis and decreased renal blood flow (each P<.001). Glomerular filtration rate decreased during L-NMMA administration (P<.001) and did not change during indomethacin administration. Combined administration of icatibant and indomethacin or L-NMMA caused significant decreases in renal excretory and hemodynamic functions, which were not different from changes observed with icatibant alone. The failure of icatibant to change renal function after inhibition of cyclooxygenase and nitric oxide synthase activity suggests that the effects of kinin B 2 receptor are mediated by intrarenal prostaglandin E 2 and nitric oxide generation. The increase in renal interstitial fluid bradykinin during icatibant requires further study of possible alterations in kinin synthesis, degradation, or clearance as a result of B 2 receptor blockade. Key Words: bradykinin interstitium sodium kidney microdialysis cyclic GMP prostaglandin E 2
2 INTRODUCTION Considerable evidence now suggests that the renal kallikrein-kinin system is involved in the regulation of sodium and water excretion and may participate in blood pressure control. Kinins can stimulate production of both NO and eicosanoids. 1 2 At least a portion of the renal effects of kinins appears to be mediated by prostaglandins, 3 and inhibition of NO synthesis reduces the renal vasodilator response to bradykinin. 4 In previous studies, intrarenal infusions of bradykinin in anesthetized dogs resulted in an increase in RPF and U Na V. 5 6 However, the biochemical and physiological effects of exogenously administered kinins may differ from those of endogenously formed kinins. 7 Administration of Fab fragments of kinin antibodies, bradykinin antagonist, 8 and Fab fragments of monoclonal antibodies to rat urinary kallikrein (Fab-kallikrein) 9 decreased UV, U Na V, and PGE 2 excretion in rats. The purpose of the present study was to investigate the effects of kinin B 2 receptor blockade on intrarenal levels of bradykinin, PGE 2, and cgmp, an indirect measure of NO generation. Because previous studies showed that urinary 10 and renal interstitial 11 kinins increase in response to sodium depletion, we carried out our studies in conscious dogs in sodium metabolic balance at 5 meq/d. We used a potent and specific bradykinin B 2 receptor antagonist, D-Arg-Arg- Pro-Hyp-Gly-Thi-Ser-L-Tic-Oic-Arg (Hoe 140, icatibant) (Hoechst AG), to begin to evaluate the role of intrarenal bradykinin and this receptor in the regulation of renal levels of PGE 2 and NO in conscious, uninephrectomized dogs. METHODS Renal Microdialysis Technique For the determination of RIF kinin, PGE 2, and cgmp, we constructed a microdialysis probe as previously described Each end of a 1-cm-long hollow fiber dialysis tube (0.3 mm ID; molecular mass cutoff, D; Hospal) was inserted into a manually dilated end of two 30-cm-long (inflow and outflow) hollow polyethylene tubes (0.12 mm ID, 0.65 mm OD; Bioanalytical Systems). The distance between the ends of the polyethylene tubes was 3 mm (dialysis area), and the dialysis fiber was sealed in place within the polyethylene tubes with cyanoacrylic glue. The dead volume of the dialysis tubing and outflow tube was 3.6 µl. The known kinin-, eicosanoid-, and NO-generating and -degrading enzymes (molecular weights, to ) will not cross the dialysis membrane because of their size. The microdialysis probe was sterilized by a gas sterilization method. Animal Preparation and RIF Collection The study protocol was approved by the University of Virginia Animal Research Committee. All studies were carried out in conscious animals to avoid disturbances in renal hormones and function induced by anesthesia. 16 Ten female mongrel dogs weighing 15 to 20 kg (mean±se, 18±0.89 kg) were used in this study. Surgery with dogs under
3 halothane anesthesia was performed as described previously for cannula insertion into the right renal artery, aorta, and inferior vena cava. 17 An ultrasonic flow probe (Transonic Systems) was placed around the right renal artery 18 for measurement of renal blood flow. A left nephrectomy was performed to eliminate renal compensation and avoid ureteral catheterization in conscious dogs. All cannulas and the wires for the right renal flow probe were tunneled subcutaneously through a bevel-tipped stainless steel tube and exteriorized in separate small stab wounds near the interscapular region. For placement of the microdialysis probe, the right renal capsule was penetrated with an 18-gauge needle that was tunneled under the capsule for 2 cm before exiting again. One end of the dialysis probe then was pulled through the needle until the dialysis fiber was situated in the outer renal cortex about 2 mm from the kidney surface. The needle then was withdrawn. The two ends of the dialysis probe (inflow and outflow tubes) were tunneled under the skin and exited near the interscapular region. The exterior ends of the vascular cannulas and microdialysis probe were protected in the pocket of a close-fitting nylon jacket (Alice King Chatham). In an earlier study, 15 a histological examination of the renal tissue 6 weeks after insertion of the dialysis probe did not show any significant fibrosis or scarring. Three weeks was allowed for recovery after surgery. General Animal Care Prevention of clot formation inside the cannulas was ensured by daily flushing with 3 ml of 10% heparin solution (Elkins Sinn). Cannulas also were flushed after each withdrawal of blood or hemodynamic measurement. As a prophylactic measure, antibiotic treatment with 250 mg ampicillin IM (Wyeth-Ayerst Laboratories) twice daily was started immediately after surgery and continued for 7 days. Body temperatures were measured twice daily during the first week after surgery and twice weekly thereafter. Blood urea nitrogen and serum creatinine levels were determined twice weekly (Serometer model 370, Mallinckrodt). Dogs were excluded from the study in the event of elevated temperature or abnormalities (blood urea nitrogen >20 mg/dl, creatinine >1.5 mg/dl) in these tests. Hematocrit levels were 41% to 46% (mean±se, 43.6±0.87%) and 41% to 45% (42.6±0.82%) before surgery and on the day of the acute study, respectively. Hemodynamic Measurements Systemic arterial pressure was monitored continuously during the acute study from the aortic cannula with a Statham P23 DB pressure transducer and Gould 2400 recorder, as previously described. 17 Mean arterial blood pressure was calculated as the mean of three recordings lasting 15 seconds each and taken at 2-minute intervals at the middle of the control and icatibant infusion periods. Analytic Methods Urinary sodium concentrations were measured by an autoanalyzer (NOVA-1, NOVA Biomedical). Venous blood samples (1 ml) for aldosterone measurements were collected at the middle of each experimental period in glass tubes coated with lithium heparin. Peripheral PAC was measured by a Coat-a-Count radioimmunoassay kit (Diagnostic Products). Peripheral venous blood (1 ml) for the determination of PRA was collected at the middle of each experimental period in tubes that contained EDTA (4 C), and plasma
4 was separated after centrifugation and stored at -70 C. Peripheral PRA was measured by radioimmunoassay of angiotensin I generation after 3 hours of incubation 19 with reagents obtained from New England Nuclear. RIF kinin, PGE 2, and cgmp samples were stored at C until they were measured by radioimmunoassays. Sodium and Fluid Balance Sodium metabolic balance was established in all dogs by placing each dog on a palatable diet containing 5 mmol sodium/d (Hills' H/D) for 15 days. All dogs were in low sodium balance for 10 days before study. The rationale for use of the low sodium diet is provided by our previous study 15 which showed that this diet increases renal interstitial kinins in the conscious dog as well as other work suggesting that the renal kallikrein-kinin system is activated by this maneuver. 10 Dietary potassium intake was 40 meq/d. Dogs had free access to water during the study. They were kept in metabolic cages; 24-hour urine collections were made, and U Na V was measured to confirm the state of sodium balance. For collection of RIF bradykinin, PGE 2, and cgmp samples, the microdialysis inflow tube was connected to a gas-tight syringe filled with lactated Ringer's solution and perfused at 3 µl/min (pump 22, Harvard Apparatus). At this perfusion rate, in vitro recovery was 78% for bradykinin 15 and 70% for cgmp. 11 The effluent was collected from the outflow tube. For kinin measurements, effluent was collected in nonheparinized plastic tubes containing 0.1 ml ethanol. The effluent for PGE 2 and cgmp measurements was collected in plastic tubes on ice. Effects of Acute Intrarenal Administration of Icatibant On the day of the acute study, a Foley catheter was inserted into the bladder for urine collections. The dogs (group 1, n=5) rested quietly in a canvas sling from 8 AM until the completion of each study. The dogs were infused intravenously with inulin (Sigma Chemical Co). Five percent dextrose solution (D5W, Travenol Laboratories) was infused intrarenally at 1.0 ml/min as a vehicle for the agent. A 90-minute period was allowed for equilibration, followed by a 60-minute control period of urine and interstitial fluid collection. After the control period, and with the continuation of interstitial fluid and urine collection, icatibant (99% purity, Peninsula Laboratories) was administered intrarenally (100 ng/kg per minute) for 180 minutes. This infusion rate caused no systemic effects in preliminary studies. Icatibant was prepared initially from lyophilized powder in D5W vehicle and sterilized by filtration (Millipore filters). Blood pressure was monitored as previously described. Changes in RIF kinin, PGE 2, and cgmp; PAC; and PRA were determined during intrarenal administration of D5W as a vehicle for icatibant (control period) and during intrarenal administration of icatibant (experimental period). Blood samples (5 ml) for PRA, PAC, and inulin measurements were obtained in the middle of each urine collection period. GFR was calculated on the basis of inulin clearance. Renal blood flow (RBF) was measured by an ultrasonic renal flow probe, and RPF was calculated as RPF=RBF(1-Hematocrit). Time Control Studies After sodium metabolic balance of 5 meq sodium/d was established, dogs (n=5) were infused intravenously with inulin. A study similar to that described above was carried out,
5 with the exception that after the control period, D5W was administered intrarenally instead of the kinin B 2 receptor blocker. Changes in renal function; RIF kinin, PGE 2, and cgmp; PAC; and PRA were determined as stated above. Effects of Intrarenal Administration of Icatibant and Indomethacin Alone or Combined To evaluate whether PGE 2 mediates the observed changes in renal function during bradykinin receptor blockade with icatibant, we repeated the above study of intrarenal administration of the kinin B 2 receptor blocker icatibant (100 ng/kg per minute) in another group of dogs (group 2, n=5) on a low sodium diet at 5 mmol/d. Under the same metabolic conditions, the study was repeated on a different day except that indomethacin (Merck) was given at 0.1 µg/kg per minute for 30 minutes instead of icatibant. This was followed by another 30 minutes of intrarenal administration of indomethacin (0.1 µg/kg per minute) and icatibant (100 ng/kg per minute). This indomethacin dose has been shown to cause a 50% reduction in renal venous plasma immunoreactive prostaglandins. 18 Effects of Intrarenal Administration of L-NMMA To evaluate whether NO mediates the observed changes in renal function during icatibant administration, we repeated the above study (group 2, n=5), except that we administered the NO synthase inhibitor L-NMMA (Bachem Bioscience Inc) at 60 µg/kg per minute instead of indomethacin. This was followed by another 30 minutes of intrarenal administration of L-NMMA (60 µg/kg per minute) and icatibant (100 ng/kg per minute). Intrarenal administration of L-NMMA at 60 µg/kg per minute was shown to decrease renal excretory and hemodynamic functions and RIF cgmp. 19 Statistical Analysis of Data Data were examined by ANOVA, including a repeated measures term, using the SAS general linear model procedure (SAS Institute). Comparison between effects of infused drugs and vehicle alone were conducted with a paired t test. Data are expressed as mean±se. Statistical significance was identified at a level of P<.05. RESULTS Renal Excretory and Hemodynamic Changes in Response to Intrarenal Icatibant U Na V on the day before study was 4.5±0.2 mmol/24 h. UV was stable during intrarenal vehicle administration (time control). In contrast, UV was 1.04±0.06 ml/min during the control period and fell markedly to 0.58±0.08 (P<.01) in response to icatibant (experimental period) (Fig 1 ). Similarly, U Na V did not change during the time control study. U Na V was 18.9±1.6 µmol/min before administration of intrarenal icatibant and fell 76% during its infusion to 4.6±0.8 (P<.01).
6 Figure 1. UV, U Na V, and RPF before and after intrarenal administration of the bradykinin antagonist icatibant ( ) or vehicle ( ) in uninephrectomized conscious dogs (n=5) in metabolic balance at a sodium intake of 5 meq/d. *P<.01. RPF was stable during the time control study. It was 111±8 ml/min during the control period and decreased to 79±10 (P<.01) during intrarenal icatibant administration (Fig 1 ). No significant change in GFR was produced by intrarenal vehicle administration (time control) or icatibant (23.4±1.7 versus 22.8±1.6 ml/min, control versus icatibant). RIF Kinin, PGE 2, and cgmp During the time control study, no changes in RIF kinin, PGE 2, or cgmp were observed. In contrast, kinin measured by radioimmunoassay in dialysates collected during control periods was 32±4.3 pg/min and increased significantly to 122±15 (P<.01) during icatibant administration (Fig 2 ). To rule out the possibility of the drug interfering with bradykinin measurements in the radioimmunoassay, we also added icatibant in excess (1 µg) to the bradykinin standards. It did not interfere with bradykinin binding compared with bradykinin standard curves (n=3). These data show that the elevated kinin level after drug is not a result of its recognition by the kinin antiserum. In addition, dog serum kininase II activity was measured by a commercial radioimmunoassay (Hycor Biomedical Inc) in the presence and absence of icatibant (1 µg per tube). The kininase II activity was 112±6.8 U
7 in the absence of icatibant and 108±5.2 U in its presence, suggesting that the drug does not inhibit kininase II activity. Figure 2. RIF bradykinin (BK), PGE 2, and cgmp before and after intrarenal administration of the bradykinin antagonist icatibant ( ) or vehicle ( ) in uninephrectomized conscious dogs (n=5) in metabolic balance at a sodium intake of 5 meq/d. *P<.01. In contrast to the kinin levels in the same dogs, the PGE 2 appearance rate decreased during icatibant administration from 11.4±0.4 pg/min during the control periods to 5.1±0.3 during drug infusion (P<.01). The renal cgmp appearance rate also decreased from 0.65±0.03 pmol/min during the control period to 0.31±0.01 during drug infusion (P<.01). Responses to Intrarenal Infusion of Icatibant, Indomethacin, or L-NMMA Individually or Combined Table 1 shows the lack of response of PRA, PAC, and mean arterial blood pressure to intrarenal icatibant, indomethacin, or L-NMMA individually or combined.
8 Study (Agent Infused) PRA, (ng/ml)/h MAP, mm Hg PAC, ng/dl Time control studies Control (D5W) 4.0± ± ±3.6 Control (D5W) 4.1± ± ±3.4 Control (D5W) 4.0± ± ±1.9 Icatibant studies Control (D5W) 4.1± ± ±2.1 Icatibant 4.2± ± ±3.6 Indomethacin+icatibant studies Control (D5W) 3.9± ± ±2.9 Indomethacin 4.0± ± ±4.9 Indomethacin+icatibant 4.0± ± ±4.2 L-NMMA+icatibant studies Control (D5W) 4.1± ± ±3.6 L-NMMA 4.1± ± ±4.1 L-NMMA+icatibant 4.0± ± ±2.4 Abbreviations as in the Selected Abbreviations and Acronyms box; MAP, mean arterial pressure; and D5W, 5% dextrose solution. Values are mean±se. Table 1. Hormonal and Pressure Responses to Intrarenal Icatibant, Indomethacin, and L- NMMA Individually or Combined Changes in Response to Intrarenal Administration of Icatibant or Indomethacin Individually or Combined Similar to the first group of dogs, icatibant caused significant decreases in UV, U Na V, and RPF (P<.001) and did not affect GFR (Table 2 ). Indomethacin caused a significant decrease in UV and U Na V from 1.1±0.04 to 0.8±0.05 ml/min and 20.0±2.1 to 8.6±1.1 µmol/min, respectively (each P<.001). RPF and GFR did not change significantly. UV decreased significantly from 1.1±0.08 to 0.7±0.04 ml/min, U Na V from 22.6±2.2 to 8.8±0.7 µmol/min, and RPF from 111±6.8 to 99±4.8 ml/min compared with control
9 (each P<.001) during combined intrarenal administration of indomethacin and icatibant. GFR did not change significantly during combined administration of indomethacin and icatibant. Combined administration of indomethacin and icatibant did not produce significant changes in the measured renal parameters over changes observed during administration of indomethacin alone. Study (Agent Infused) UV, ml/min U Na V, µmol/min RPF, ml/min GFR, ml/min Time control studies Control (D5W) 1.06± ± ±7.6 24±1.7 Control (D5W) 1.1± ± ±8.7 26±2.4 Control (D5W) 1.0± ± ±6.8 26±1.6 Icatibant studies Control (D5W) 1.0± ± ±8.5 24±1.6 Icatibant 0.6± ±0.8 82±5.6 24±1.9 Indomethacin+icatibant studies Control (D5W) 1.1± ± ±8.5 26±1.7 Indomethacin 0.8±0.05* 8.6±1.1* 100±5.1 25±1.2 Indomethacin+icatibant 0.7± ±0.7 99±4.8* 24±0.7 L-NMMA+icatibant studies Control (D5W) 1.1± ± ±2.1 25±2.6 L-NMMA 0.5± ±0.6 88±3.2* 21±0.6* L-NMMA+icatibant 0.5± ±0.7 86±3.3* 21±2.0* Abbreviations as in the Selected Abbreviations and Acronyms box and Table 1. Values are mean±se. *P<.05, P<.001 compared with vehicle control; P<.05 compared with icatibant alone. Table 2. Renal Excretory and Hemodynamic Responses to Intrarenal Icatibant, Indomethacin, or L-NMMA Individually or Combined Changes in Response to Intrarenal L-NMMA Alone or Combined With Icatibant L-NMMA caused a significant decrease in UV from 1.1±0.07 to 0.5±0.03 ml/min, U Na V from 21.2±2.0 to 6.2±0.6 µmol/min, RPF from 113±2.1 to 88±3.2 ml/min, and GFR from 25±2.6 to 21±0.6 ml/min (each P<.001) (Table 2 ). These renal excretory and hemodynamic parameters continued to decrease during combined intrarenal
10 administration of L-NMMA and icatibant but were not significantly different from changes with L-NMMA alone. DISCUSSION Current knowledge suggests that the renal kallikrein-kinin system participates in the control of water and electrolyte excretion and regulation of blood pressure. 7 Bradykinin is known to release either NO or eicosanoids from vascular endothelial, renal interstitial, or epithelial cells. 1 2 At least a portion of the renal effects of kinins is thought to be mediated by these messengers. 3 However, a lack of specific tools to interrupt the kallikrein-kinin system, as well as a lack of methodology to measure its local in situ activity, has made it difficult to clearly delineate the roles of kinins in the regulation of renal hemodynamic and excretory functions. Here, we were able to test the hypothesis that intrarenal bradykinin plays a role in the regulation of renal function either directly or through eicosanoids and NO in conscious dogs using icatibant, a specific kinin B 2 receptor antagonist, 23 while measuring RIF mediators concomitantly with some renal functional parameters. We reasoned that if kinins act locally within the kidney to regulate renal function and renal generation of eicosanoids and NO, then intrarenal bradykinin receptor blockade should evoke measurable changes in both. Acute administration of icatibant during a period of chronic low sodium balance caused significant antidiuresis and antinatriuresis and decreased RPF, whereas GFR remained unchanged. This is in agreement with a previous study using a different B 2 receptor blocker. 18 In that study, the kinin receptor antagonist decreased UV and U Na V in dogs during low sodium but not during high sodium intake. Collectively, these results may relate to the observation that a chronic low sodium diet is associated with high renal interstitial kinin levels, whereas during a high sodium diet, such levels are barely detectable. 11 It is still unclear why an increase in the renal interstitial level of kinin occurs in response to a reduction in dietary sodium intake. However, the activation of the renal kallikrein-kinin system during chronic low sodium intake suggests that the system functions to counteract antinatriuretic or vasoconstrictor mechanisms activated in response to sodium depletion. It is unlikely that the observed increase in intrarenal bradykinin levels displaced the icatibant from B 2 receptors. If this happened, an opposite response to what we observed in this study should occur. Studies in rats treated with deoxycorticosterone acetate and salt 8 showed a decrease in UV and U Na V in response to Fab-bradykinin and a decrease in UV in response to bradykinin antagonist. Neither altered blood pressure, renal blood flow, or GFR. 8 In another study, 9 Fab-kallikrein decreased kinin excretion, UV, and U Na V and slightly decreased urinary PGE 2 excretion in rats on a normal sodium diet. Fab-kallikrein did not alter blood pressure, renal blood flow, or GFR. 9 In contrast to previous studies, the present study is the first to report changes in RIF kinin, PGE 2, and cgmp in conscious dogs on a low sodium metabolic
11 balance. Kinins can be formed and degraded in urine, and their measurement in RIF would avoid this problem. The antinatriuresis associated with icatibant administration is associated with a decrease in RPF and no change in GFR. Both indomethacin, a cyclooxygenase inhibitor, and L- NMMA, an NO synthase inhibitor, caused a decrease in UV, U Na V, and RPF. A decrease in GFR was observed only during L-NMMA administration. Combined administration of the B 2 receptor antagonist icatibant with either indomethacin or L-NMMA caused a decrease in UV, U Na V, and RPF. There was a lack of a synergistic effect between indomethacin and icatibant, which suggests that the effects of both agents are due to inhibition of renal kinin action. Combined icatibant and L-NMMA significantly decreased GFR. The reason for the discrepancy between the effects of icatibant alone and combined icatibant and L-NMMA on GFR is that renal hormones other than bradykinin can stimulate NO. 24 It is expected that icatibant administration will not completely abolish renal NO production, whereas L-NMMA, by inhibiting the NO synthase, can produce a further decrease in renal NO levels, thereby possibly explaining the observed difference in GFR response. The decrease in RPF during icatibant and L-NMMA treatments was more pronounced than its decrease during indomethacin administration. This could be mainly due to a decrease in renal NO associated with icatibant and L- NMMA. The observed effects of indomethacin are consistent with previous studies showing that indomethacin is less effective in reducing RPF in conscious dogs. 25 It is important to note that the responses observed in our uninephrectomized conscious dogs may be different in other animal models (ie, anesthetized or two-kidney model). Collectively, these data suggest that renal effects of acute administration of icatibant might be mediated by both local hemodynamic and tubular mechanisms, including the partial blockade of eicosanoids or NO release Since there is a correlation between NO-induced vasodilation and NO-induced cgmp accumulation in vascular smooth muscle cells, cgmp accumulation can be a useful tool for estimation of NO release. Our ability to detect changes in the levels of RIF bradykinin, PGE 2, and cgmp with variations in salt intake 11 suggests that these substances play a role in the regulation of renal function. The observed increase in RIF bradykinin during administration of a kinin B 2 receptor blocker could result from decreased bradykinin uptake, degradation, or clearance mediated by B 2 receptors. In this study, icatibant did not affect kininase II (angiotensinconverting enzyme) activity in serum; however, we do not know whether the agent affected intrarenal kinin degradation, although we are unaware of any such effect. Since the bradykinin antiserum used in the radioimmunoassay failed to recognize icatibant, it is unlikely that an assay artifact caused the unexpected increase in RIF bradykinin. In the present study, it is not clear whether the increased levels of RIF bradykinin during icatibant administration influence B 1 receptor activity. It has been reported that both B 1 and B 2 receptors mediate vasodilation in canine renal arteries in vitro 26 and in vivo. 27 B 1 receptor blockade causes transient decreases in U Na V. 23 Thus, it is possible that the increase in RIF bradykinin may stimulate B 1 receptors; however, renal blood flow and U Na V should increase, which is opposite to our findings. This interesting possibility can be addressed in future work assessing the relative contributions of these different receptor populations to canine renal function.
12 The decreased levels of RIF PGE 2 and cgmp during the acute B 2 receptor antagonist while dogs were on a low sodium diet suggest that bradykinin partially mediates the generation of these substances in the kidney. The simultaneous decreases in U Na V and RPF during acute icatibant, indomethacin, or L-NMMA administration suggest that these renal functions are influenced by intrarenal kinin generation, PGE 2, and NO. These data represent acute responses to B 2 receptor blockade. Furthermore, the failure of icatibant to decrease renal excretory and hemodynamic functions after intrarenal cyclooxygenase and NO synthase inhibition suggests that the renal effects of kinins are mediated by eicosanoids and NO. SELECTED ABBREVIATIONS AND ACRONYMS GFR = glomerular filtration rate L-NMMA = N G -monomethyl-l-arginine NO = nitric oxide PAC = plasma aldosterone concentration PGE 2 = prostaglandin E 2 PRA = plasma renin activity RIF = renal interstitial fluid RPF = renal plasma flow U Na V = urinary sodium excretion UV = urine flow rate ACKNOWLEDGMENTS This work was supported by grants HL-47669, HL-17705, and HL from the National Heart, Lung, and Blood Institute, National Institutes of Health, to H.M.S. or to H.S.M. Dr Helmy M. Siragy is the recipient of a Research Career Development Award (1 K04 HL-03006) from the National Institutes of Health, Bethesda, Md. Received February 21, 1996; first decision March 26, 1996; first decision October 2, 1996;
13 REFERENCES 1. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333: Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest ;93: Terragno NA, Lonigro AJ, Malik KU, McGiff JC. The relationship of the renal vasodilator action of bradykinin to the release of a prostaglandin E-like substance. Experientia. 1972;28: Fulton D, McGiff JC, Quilley J. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol. 1992;107: Flamenbaum W, Gagnon J, Ramwell P. Bradykinin-induced renal hemodynamic alterations: renin and prostaglandin relationships. Am J Physiol. 1979;237:F433- F Beierwalters W, Carretero OA, Scicli AG. Renal hemodynamics in response to a kinin analogue antagonist. Am J Physiol. 1988;255:F408-F Carretero OA, Scicli AG. The renal kallikrein-kinin system. Am J Physiol. 1980;238:F247-F Tomiyama H, Scicli AG, Scicli GM, Carretero OA. Renal effects of Fab fragments of kinin antibodies on deoxycorticosterone acetate-salt treated rats. Hypertension. 1990;15: Saitoh S, Scicli AG, Peterson E, Carretero OA. Effect of inhibiting renal kallikrein on prostaglandin E 2, water, and sodium excretion. Hypertension. 1995;25: Barabe J, Huberdeau D, Bernoussi A. Influence of sodium balance on urinary excretion of immunoreactive kinins in rats. Am J Physiol. 1988;254:F484-F Siragy HM, Ibrahim MM, Jaffa AA, Mayfield R, Margolius HS. Rat renal interstitial bradykinin, prostaglandin E 2, and cyclic guanosine 3',5'- monophosphate: effects of altered sodium intake. Hypertension. 1994;23(part 2): Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke St, Breipohl G, Konig W, Knolle J, Scholkens BA. HOE 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol. 1991;102:
14 13. Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henke ST, Breipohl G, Konig W, Knolle J, Scholkens BA. HOE 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol. 1991;102: Siragy HM, Johns RA, Peach MJ, Carey RM. Nitric oxide alters renal function and guanosine 3'5'-cyclic monophosphate. Hypertension. 1992;19: Siragy HM, Jaffa AA, Margolius HS. Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens. 1993;6: Johnson MD, Malvin RL. Plasma renin activity during pentobarbital anesthesia and gradual hemorrhage in dogs. Am J Physiol. 1975;229: Dickstein GM, Woodson JF, Lamb NE, Rose CE Jr, Peach MJ, Carey RM. Escape from the sodium retaining action of intrarenal angiotensins II and III in the conscious dog. Endocrinology. 1985;117: Siragy HM. Evidence that intrarenal bradykinin plays a role in regulation of renal function. Am J Physiol. 1993;265:E648-E Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med. 1977;2: Shimamato K, Ando T, Nakoo T, Tanaka S, Sakum M, Miyahara M. A sensitive radioimmunoassay method for urinary kinins in man. J Lab Clin Med. 1978;91: Harper JF, Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucl Res. 1975;1: Powell WS. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 1980;20: Bao G, Qadri F, Stauss B, Stauss H, Gohlke P, Unger T. HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats. Eur J Pharmacol. 1991;200: Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev ;43: Terragno NA, Malik KU, Nasjletti A, Terragno DA, McGiff JC. Renal prostaglandins. Adv Prostaglandin Thromboxane Res. 1976;2:
15 26. Rhaleb NE, Dion S, Barabe J, Roussi N, Jukie D, Drapeau G, Regoli D. Receptors for kinins in isolated arterial vessels of dogs. Eur J Pharmacol. 1989;162: [Medline] 27. Lortie M, Regoli D, Rhaleb N, Plante GE. The role of B 1 - and B 2 -kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Physiol. 1992;262:R72-R76.
Helmy M. Siragy and Robert M. Carey Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908
Rapid Publication The Subtype 2 (AT 2 ) Angiotensin Receptor Mediates Renal Production of Nitric Oxide in Conscious Rats Helmy M. Siragy and Robert M. Carey Department of Medicine, University of Virginia
More informationHELMY M. SIRAGY*, TADASHI INAGAMI, TOSHIHIRO ICHIKI, AND ROBERT M. CAREY* METHODS
Proc. Natl. Acad. Sci. USA Vol. 96, pp. 6506 6510, May 1999 Physiology Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT 2 ) angiotensin receptor (blood pressure
More informationhad no effect on the production of aldosterone, corticosterone, or cortisol after
INHIBITION OF THE EFFECTS OF ANGIOTENSIN II ON ADRENAL STEROID PRODUCTION BY DIETARY SODIUM BY WARREN W. DAVIS,* LAWRENCE R. BURWELL,t AND FREDERIC C. BARTTERt ENDOCRINOLOGY BRANCH, NATIONAL HEART INSTITUTE,
More informationmodulating the tubuloglomerular feed-back mechanism in the canine kidney; Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, U.S.A.
J. Physiol. (1986), 380, pp. 35-43 35 With 3 text-figures Printed in Great Britain RENAL VASOCONSTRICTOR RESPONSE TO HYPERTONIC SALINE IN THE DOG: EFFECTS OF PROSTAGLANDINS, INDOMETHACIN AND THEOPHYLLINE
More informationThe ability of the kidneys to regulate extracellular fluid volume by altering sodium
REGULATION OF EXTRACELLULAR FLUID VOLUME BY INTEGRATED CONTROL OF SODIUM EXCRETION Joey P. Granger Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi
More informationEffect of Sodium Loading and Depletion on Cyclic Nucleotides in Plasma and Aorta. Interaction between Prostacyclin and Cyclic Nucleotides
Endocrinol. Japon. 1982, 29 (2), 245-250 Effect of Sodium Loading and Depletion on Cyclic Nucleotides in Plasma and Aorta. Interaction between Prostacyclin and Cyclic Nucleotides MANABU YOSHIMURA, TERUO
More informationPaul M McKie, Alessandro Cataliotti, Guido Boerrigter, Horng C Chen, Fernando L Martin, and John C Burnett Jr
Cardiorenal Enhancing and Aldosterone Suppressing Actions of a Novel Designer Natriuretic Peptide in Experimental Hypertension with Ventricular Pressure Overload Paul M McKie, Alessandro Cataliotti, Guido
More informationHypertensive and Renal Effects of Chronic Low Level Intrarenal Angiotensin Infusion in the Dog
154 Hypertensive and Renal Effects of Chronic Low Level Intrarenal Angiotensin Infusion in the Dog THOMAS E. LOHMEIER AND ALLEN W. COWLEY, JR. SUMMARY To determine whether the intrarenal sodium-retaining
More informationA study of the action of bradykinin and bradykinin analogues
NS 214, pp. 351-356 Journal of Physiology (1994), 478.2 351 A study of the action of bradykinin and bradykinin analogues in the human nasal airway C. E. Austin and J. C. Foreman* Department of Pharmacology,
More informationRegulation of fluid and electrolytes balance
Regulation of fluid and electrolytes balance Three Compartment Fluid Compartments Intracellular = Cytoplasmic (inside cells) Extracellular compartment is subdivided into Interstitial = Intercellular +
More informationEstimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1
Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance BCH472 [Practical] 1 -Kidney functions: - The kidneys serve three essential functions: 1. They function as filters, removing metabolic
More informationHEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease
HEALTHYSTART TRAINING MANUAL Living well with Kidney Disease KIDNEY DISEASE CAN AFFECT ANYONE! 1 HEALTHYSTART PROGRAMME HEALTHYSTART is a lifestyle management programme to assist you to remain healthy
More informationTHE EFFECTS OF AN ANGIOTENSIN BLOCKER (SARALASIN) ON KIDNEY FUNCTION IN DEHYDRATED SHEEP
Quarterly Journal of Experimental Physiology (1982) 67, 97-103 Printed in Great Britain THE EFFECTS OF AN ANGIOTENSIN BLOCKER (SARALASIN) ON KIDNEY FUNCTION IN DEHYDRATED SHEEP NANCY E. YESBERG, MYRNA
More informationBLOCK REVIEW Renal Physiology. May 9, 2011 Koeppen & Stanton. EXAM May 12, Tubular Epithelium
BLOCK REVIEW Renal Physiology Lisa M. HarrisonBernard, Ph.D. May 9, 2011 Koeppen & Stanton EXAM May 12, 2011 Tubular Epithelium Reabsorption Secretion 1 1. 20, 40, 60 rule for body fluid volumes 2. ECF
More informationInterrelationship between Angiotensin Catecholamines. Tatsuo SATO, M.D., Masaru MAEBASHI, M.D., Koji GOTO, M.D., and Kaoru YOSHINAGA, M.D.
Interrelationship between Angiotensin and Catecholamines Tatsuo SATO, M.D., Masaru MAEBASHI, M.D., Koji GOTO, M.D., and Kaoru YOSHINAGA, M.D. SUMMARY Urinary catecholamines were measured with an attempt
More informationBCH472 [Practical] 1
BCH472 [Practical] 1 1. They function as filters, removing metabolic products and toxins from the blood and excreting them through the urine. 2. They regulate the body s fluid status, electrolyte balance,
More informationRENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D.
RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D. Learning Objectives 1. Identify the region of the renal tubule in which reabsorption and secretion occur. 2. Describe the cellular
More informationRenal-Related Questions
Renal-Related Questions 1) List the major segments of the nephron and for each segment describe in a single sentence what happens to sodium there. (10 points). 2) a) Describe the handling by the nephron
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More informationEXCRETION QUESTIONS. Use the following information to answer the next two questions.
EXCRETION QUESTIONS Use the following information to answer the next two questions. 1. Filtration occurs at the area labeled A. V B. X C. Y D. Z 2. The antidiuretic hormone (vasopressin) acts on the area
More informationThe effects of angiotensin II on blood perfusion in the rat renal papilla
9325 Journal of Physiology (1999), 519.1, pp. 273 278 273 The effects of angiotensin II on blood perfusion in the rat renal papilla L. L. Walker, A. A. J. Rajaratne, J. R. Blair-West and P. J. Harris Department
More informationRenal Blood flow; Renal Clearance. Dr Sitelbanat
Renal Blood flow; Renal Clearance Dr Sitelbanat Objectives At the end of this lecture student should be able to describe: Renal blood flow Autoregulation of GFR and RBF Regulation of GFR The Calcuation
More informationBIPN100 F15 Human Physiology (Kristan) Problem Set #8 Solutions p. 1
BIPN100 F15 Human Physiology (Kristan) Problem Set #8 Solutions p. 1 1. a. Proximal tubule. b. Proximal tubule. c. Glomerular endothelial fenestrae, filtration slits between podocytes of Bowman's capsule.
More informationRenal physiology D.HAMMOUDI.MD
Renal physiology D.HAMMOUDI.MD Functions Regulating blood ionic composition Regulating blood ph Regulating blood volume Regulating blood pressure Produce calcitrol and erythropoietin Regulating blood glucose
More information(Received 23 January 1961) Crawford & Kennedy (1959) found the prolonged saluretic and diuretic
454 J. Phyeiol. (1961), 157, pp. 454-461 With 3 text-figure Printed in Great Britain THE ACTION OF CHLOROTHIAZIDE IN THE PERFUSED CAT KIDNEY BY T. DE LIMA AND MARY F. LOCKETT From the Department of Physiology
More informationCh 19: The Kidneys. Functional unit of kidneys:?? Developed by John Gallagher, MS, DVM
Ch 19: The Kidneys Homeostatic regulation of ECF volume and BP Osmolarity 290 mosm Ion balance Na+ and K+, etc. ph (acid-base balance Excretion of wastes & foreign substances Hormone production EPO Renin
More informationUrinary Kallikrein Excretion in Hypertensive Man
Urinary Kallikrein Excretion in Hypertensive Man RELATIONSHIPS TO SODIUM INTAKE AND SODIUM-RETAINING STEROIDS By Harry S. Margolius, David Horwttz, John J. Pisano, and Harry R. Kelser ABSTRACT Urinary
More informationA&P 2 CANALE T H E U R I N A R Y S Y S T E M
A&P 2 CANALE T H E U R I N A R Y S Y S T E M URINARY SYSTEM CONTRIBUTION TO HOMEOSTASIS Regulates body water levels Excess water taken in is excreted Output varies from 2-1/2 liter/day to 1 liter/hour
More informationMAJOR FUNCTIONS OF THE KIDNEY
MAJOR FUNCTIONS OF THE KIDNEY REGULATION OF BODY FLUID VOLUME REGULATION OF OSMOTIC BALANCE REGULATION OF ELECTROLYTE COMPOSITION REGULATION OF ACID-BASE BALANCE REGULATION OF BLOOD PRESSURE ERYTHROPOIESIS
More informationSodium Restriction on Plasma Prostaglandin A, E and F Concentrations in Normal Humans
The Effect of Chronic Sodium Loading and Sodium Restriction on Plasma Prostaglandin A, E and F Concentrations in Normal Humans RANDALL M. ZUSMAN, DAVID SPECrOR, BURTON V. CALDWELL, LEON SPEROFF, GEORGE
More informationLecture-2 Review of the previous lecture:
Lecture-2 Review of the previous lecture: -Kidney s function is to clean the blood by the removing of the waste plus adding some valuable substances -kidney failure will lead to death for many reasons,
More informationBIPN100 F15 Human Physiology (Kristan) Lecture 18: Endocrine control of renal function. p. 1
BIPN100 F15 Human Physiology (Kristan) Lecture 18: Endocrine control of renal function. p. 1 Terms you should understand by the end of this section: diuresis, antidiuresis, osmoreceptors, atrial stretch
More informationChapter 17: Urinary System
Introduction Chapter 17: Urinary System Organs of the Urinary System REFERENCE FIGURE 17.1 2 kidneys filters the blood 2 ureters transport urine from the kidneys to the urinary bladder Urinary bladder
More informationRenal Regulation of Sodium and Volume. Dr. Dave Johnson Associate Professor Dept. Physiology UNECOM
Renal Regulation of Sodium and Volume Dr. Dave Johnson Associate Professor Dept. Physiology UNECOM Maintaining Volume Plasma water and sodium (Na + ) are regulated independently - you are already familiar
More informationUrinary System. consists of the kidneys, ureters, urinary bladder and urethra
Urinary System 1 Urinary System consists of the kidneys, ureters, urinary bladder and urethra 2 Location of Kidneys The kidneys which are positioned retroperitoneally lie on either side of the vertebral
More informationIntroduction. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats
Acute sodium overload produces renal tubulointerstitial inflammation in normal rats MI Roson, et al. Kidney International (2006) Introduction Present by Kanya Bunnan and Wiraporn paebua Tubular sodium
More informationPatterns of Sodium Excretion During Sympathetic Nervous System Arousal. Gregory A. Harshfield, Derrick A. Pulliam, and Bruce S.
1156 Patterns of Sodium Excretion During Sympathetic Nervous System Arousal Gregory A. Harshfield, Derrick A. Pulliam, and Bruce S. Alpert The purpose of this study was to examine Na + handling and regulation
More informationHyperaldosteronism: Conn's Syndrome
RENAL AND ACID-BASE PHYSIOLOGY 177 Case 31 Hyperaldosteronism: Conn's Syndrome Seymour Simon is a 54-year-old college physics professor who maintains a healthy lifestyle. He exercises regularly, doesn't
More informationFiltration and Reabsorption Amount Filter/d
Renal Physiology 2011 Lisa M. Harrison-Bernard, PhD Contact me at lharris@lsuhsc.edu Renal Physiology Lecture 3 Renal Clearance and Glomerular Filtration Filtration and Reabsorption Amount Filter/d Amount
More informationPlasma Renin Activity and Renin-Substrate Concentration in Patients with Liver Disease
Plasma Renin Activity and Renin-Substrate Concentration in Patients with Liver Disease By Carlos R. Ayers, M.D. ABSTRACT Peripheral venous renin activity was determined by the method of Boucher in 15 patients
More informationRenal Physiology - Lectures
Renal Physiology - Lectures Physiology of Body Fluids PROBLEM SET, RESEARCH ARTICLE Structure & Function of the Kidneys Renal Clearance & Glomerular Filtration PROBLEM SET Regulation of Renal Blood Flow
More informationCardiovascular System B L O O D V E S S E L S 2
Cardiovascular System B L O O D V E S S E L S 2 Blood Pressure Main factors influencing blood pressure: Cardiac output (CO) Peripheral resistance (PR) Blood volume Peripheral resistance is a major factor
More informationNephron Structure inside Kidney:
In-Depth on Kidney Nephron Structure inside Kidney: - Each nephron has two capillary regions in close proximity to the nephron tubule, the first capillary bed for fluid exchange is called the glomerulus,
More informationPhysio 12 -Summer 02 - Renal Physiology - Page 1
Physiology 12 Kidney and Fluid regulation Guyton Ch 20, 21,22,23 Roles of the Kidney Regulation of body fluid osmolarity and electrolytes Regulation of acid-base balance (ph) Excretion of natural wastes
More informationRole of Angiotensin II in the Renal Effects Induced by Nitric Oxide and Prostaglandin Synthesis Inhibition
Role of Angiotensin II in the Renal Effects Induced by Nitric Oxide and Prostaglandin Synthesis Inhibition MARIA T. LLINAS, JUAN D. GONZALEZ, EDUARDO NAVA, and F. JAVIER SALAZAR Departamento de Fisiologla,
More informationBRADYKININ-RECEPTOR BLOCKADE AND RESPONSE TO ACE INHIBITOR IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS
BRADYKININ-RECEPTOR BLOCKADE AND RESPONSE TO ACE INHIBITOR IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS EFFECT OF BRADYKININ-RECEPTOR BLOCKADE ON THE RESPONSE TO ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN
More informationalready been published [O'Connor, 1958 b]. emphasized that the most prominent action of adrenaline on the kidney is to
THE EFFECT ON THE VOLUME AND COMPOSITION OF THE URINE OF THE INFUSION OF ADRENALINE AND NORADRENALINE. By W. J. O'CoNNoR. From the Department of Physiology, School of Medicine, University of Leeds. (Received
More informationA. Correct! Flushing acids from the system will assist in re-establishing the acid-base equilibrium in the blood.
OAT Biology - Problem Drill 16: The Urinary System Question No. 1 of 10 1. Which of the following would solve a drop in blood ph? Question #01 (A) Decreased retention of acids. (B) Increased excretion
More informationHYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL
HYPERTENSION IN CKD LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Normal Increased risk Damage GFR
More informationrenoprotection therapy goals 208, 209
Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization
More informationdescribe the location of the kidneys relative to the vertebral column:
Basic A & P II Dr. L. Bacha Chapter Outline (Martini & Nath 2010) list the three major functions of the urinary system: by examining Fig. 24-1, list the organs of the urinary system: describe the location
More informationUrinary system. Lab-7
Urinary system Lab-7 Excretion: processes that remove wastes and excess materials from the body Urinary system (kidneys): excretes nitrogenous wastes, excess solutes, and water The Kidneys Regulate Water
More informationNROSCI/BIOSC 1070 and MSNBIO 2070 Exam # 2 October 25, 2013 Total POINTS: % of grade in class
NROSCI/BIOSC 1070 and MSNBIO 2070 Exam # 2 October 25, 2013 Total POINTS: 100 20% of grade in class 1) During exercise, plasma levels of Renin increase moderately. Why should Renin levels be elevated during
More informationACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response
Editorial review Keywords: ACE inhibition, species variation Departments of Radiology and Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA Correspondence to:
More informationOsmotic Regulation and the Urinary System. Chapter 50
Osmotic Regulation and the Urinary System Chapter 50 Challenge Questions Indicate the areas of the nephron that the following hormones target, and describe when and how the hormones elicit their actions.
More informationPhysiology Lecture 2. What controls GFR?
Physiology Lecture 2 Too much blood is received by the glomerular capillaries, this blood contains plasma, once this plasma enters the glomerular capillaries it will be filtered to bowman s space. The
More informationRelation Between Sodium Intake, Renal Function, and the Regulation of Arterial Pressure. Jeffrey L. Osborn
1-91 Relation Between Sodium Intake, Renal Function, and the Regulation of Arterial Pressure Jeffrey L. Osborn The long-term regulation of arterial pressure requires the maintenance of a balance between
More informationMeasurement of Renin Activity using Tandem Mass Spectrometry Ravinder J Singh, PhD, DABCC Mayo Clinic, Rochester, MN
Measurement of Renin Activity using Tandem Mass Spectrometry Ravinder J Singh, PhD, DABCC Mayo Clinic, Rochester, MN Renin Angiotension System Weber, et al. NEJM 2001; 345:1690. Renin Angiotension System
More informationRENAL PHYSIOLOGY. Zekeriyya ALANOGLU, MD, DESA Ahmet Onat Bermede, MD, Ankara University School of Medicine Dept. Anesthesiology and ICM
RENAL PHYSIOLOGY Zekeriyya ALANOGLU, MD, DESA Ahmet Onat Bermede, MD, Ankara University School of Medicine Dept. Anesthesiology and ICM Kidneys Stabilize the composition of the ECF (electrolyte, H
More informationWHY DO WE NEED AN EXCRETORY SYSTEM? Function: To eliminate waste To maintain water and salt balance To maintain blood pressure
EXCRETORY SYSTEM WHY DO WE NEED AN EXCRETORY SYSTEM? Function: To eliminate waste To maintain water and salt balance To maintain blood pressure These wastes include: Carbon dioxide Mostly through breathing
More information1. Urinary System, General
S T U D Y G U I D E 16 1. Urinary System, General a. Label the figure by placing the numbers of the structures in the spaces by the correct labels. 7 Aorta 6 Kidney 8 Ureter 2 Inferior vena cava 4 Renal
More informationIntroduction to the kidney: regulation of sodium & glucose. Dr Nick Ashton Senior Lecturer in Renal Physiology Faculty of Biology, Medicine & Health
Introduction to the kidney: regulation of sodium & glucose Dr Nick Ashton Senior Lecturer in Renal Physiology Faculty of Biology, Medicine & Health Objectives Overview of kidney structure & function Glomerular
More informationAmlodipine plus Lisinopril Tablets AMLOPRES-L
Amlodipine plus Lisinopril Tablets AMLOPRES-L COMPOSITION AMLOPRES-L Each uncoated tablet contains: Amlodipine besylate equivalent to Amlodipine 5 mg and Lisinopril USP equivalent to Lisinopril (anhydrous)
More information2- Maintain the proper balance between water and. 3- Maintain the proper acid base balance. glucose by gluconeogenesis. pressure
Filter ~180 liters of blood plasma daily, allowing toxins, metabolic wastes, and excess ions to leave the body in urine 1 Regulate volume and chemical composition of the blood 2 Maintain the proper balance
More informationRenal System Physiology
M58_MARI0000_00_SE_EX09.qxd 7/18/11 2:37 PM Page 399 E X E R C I S E 9 Renal System Physiology Advance Preparation/Comments 1. Prior to the lab, suggest to the students that they become familiar with the
More informationPressure Diuresis 9 Sample Student Essays
Pressure Diuresis 9 Sample Student Essays Below please find assembled consecutively in one document the brief analyses submitted by nine students in Mammalian Physiology 08 to the Teach Yourself Pressure
More informationDefinitions. You & Your New Transplant ` 38
Definitions Acute Short, relatively severe Analgesic Pain medicine Anemia A low number of red blood cells Anesthetic Medication that dulls sensation in order to reduce pain Acute Tubular Necrosis (ATN)
More informationRegulation of Arterial Blood Pressure 2 George D. Ford, Ph.D.
Regulation of Arterial Blood Pressure 2 George D. Ford, Ph.D. OBJECTIVES: 1. Describe the Central Nervous System Ischemic Response. 2. Describe chemical sensitivities of arterial and cardiopulmonary chemoreceptors,
More informationBIOL 2402 Renal Function
BIOL 2402 Renal Function Dr. Chris Doumen Collin County Community College 1 Renal Clearance and GFR Refers to the volume of blood plasma from which a component is completely removed in one minute by all
More informationSalt and Water Balance and Nitrogen Excretion
Announcements Exam is in class on WEDNESDAY. Bring a #2 pencil and your UFID. You must come to your registered class section (except those with DRC accommodations). Office hours Mon 1-3 pm. Teaching evals:
More informationNon-protein nitrogenous substances (NPN)
Non-protein nitrogenous substances (NPN) A simple, inexpensive screening test a routine urinalysis is often the first test conducted if kidney problems are suspected. A small, randomly collected urine
More informationRenal Clearance. Dr. Eman El Eter
Renal Clearance Dr. Eman El Eter Concept of clearance Clearance is the volume of plasma that is completely cleared of a substance each minute. Example: Renal clearance of Substance X is defined as the
More informationPreparation of Animals for Live Animal Imaging
Preparation of Animals for Live Animal Imaging George A. Tanner, Ph.D. Department of Cellular and Integrative Physiology Indiana University School of Medicine Ideal Condition of Rats during Experiments:
More informationRENAL PHYSIOLOGY. Zekeriyya ALANOGLU, MD, DESA. Ahmet Onat Bermede, MD. Ankara University School of Medicine Dept. Anesthesiology and ICM
RENAL PHYSIOLOGY Zekeriyya ALANOGLU, MD, DESA. Ahmet Onat Bermede, MD. Ankara University School of Medicine Dept. Anesthesiology and ICM Kidneys Stabilize the composition of the ECF (electrolyte,
More informationCONTROLLING THE INTERNAL ENVIRONMENT
AP BIOLOGY ANIMAL FORM & FUNCTION ACTIVITY #5 NAME DATE HOUR CONTROLLING THE INTERNAL ENVIRONMENT KIDNEY AND NEPHRON NEPHRON FUNCTIONS Animal Form & Function Activity #5 page 1 NEPHRON STRUCTURE NEPHRON
More informationFunctions of the kidney
Physiology of Urinary tract Kidney, Ureter, Urinary bladder Urethra Kidney function Excretion Physiology of volume regulation Functions of the kidney Excretion of dangerous substances endogenous (metabolites):
More informationInfluence of Prostaglandin E 2, Indomethacin, and Reserpine on Renal Vascular Responses to Nerve Stimulation, Pressor and Depressor Hormones
72 Influence of Prostaglandin E 2, Indomethacin, and Reserpine on Renal Vascular Responses to Nerve Stimulation, Pressor and Depressor Hormones GREGORY D. FINK, BARRY M. CHAPNICK, MICHAEL R. GOLDBERG,
More informationNephron Anatomy Nephron Anatomy
Kidney Functions: (Eckert 14-17) Mammalian Kidney -Paired -1% body mass -20% blood flow (Eckert 14-17) -Osmoregulation -Blood volume regulation -Maintain proper ion concentrations -Dispose of metabolic
More information** TMP mean page 340 in 12 th edition. Questions 1 and 2 Use the following clinical laboratory test results for questions 1 and 2:
QUESTION Questions 1 and 2 Use the following clinical laboratory test results for questions 1 and 2: Urine flow rate = 1 ml/min Urine inulin concentration = 100 mg/ml Plasma inulin concentration = 2 mg/ml
More informationBODY FLUID. Outline. Functions of body fluid Water distribution in the body Maintenance of body fluid. Regulation of fluid homeostasis
BODY FLUID Nutritional Biochemistry Yue-Hwa Chen Dec 13, 2007 Chen 1 Outline Functions of body fluid Water distribution in the body Maintenance of body fluid Intake vs output Regulation of body fluid Fluid
More informationBasic Functions of the Kidneys
Dr. Adelina Vlad Basic Functions of the Kidneys Eliminate plasma METABOLIC WASTE PRODUCTS and FOREIGN COMPOUNDS The kidney are the primary means for eliminating metabolic waste products (urea, creatinine,
More informationOn the Adaptation in Sodium Excretion in Chronic Uremia
On the Adaptation in Sodium Excretion in Chronic Uremia THE EFFECTS OF "PROPORTIONAL REDUCTION" OF SODIUM INTAKE R. WILLIAM SCHMIDT, JACQUES J. BOURGOIGNIE, and NEAL S. BRICKER From the Division of Nephrology,
More informationRenal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology
Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics
More informationAcute Kidney Injury. I. David Weiner, M.D. Division of Nephrology, Hypertension and Transplantation University of Florida and NF/SGVHS
Acute Kidney Injury I. David Weiner, M.D. Division of Nephrology, Hypertension and Transplantation University of Florida and NF/SGVHS 374-6102 David.Weiner@medicine.ufl.edu www.renallectures.com Concentration
More informationHuman Urogenital System 26-1
Human Urogenital System 26-1 Urogenital System Functions Filtering of blood, Removal of wastes and metabolites Regulation of blood volume and composition concentration of blood solutes ph of extracellular
More informationSalt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance
Salt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance Matthew R. Weir, MD Professor and Director Division of Nephrology University of Maryland School of Medicine Overview Introduction Mechanisms
More informationThe effect of sildenafil on electrostimulation-induced erection in the rat model
(2002) 14, 251 255 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir The effect of sildenafil on electrostimulation-induced erection in the rat model N Ueno 1,
More informationContents. Page 1. Homework 11 Chapter Blood Vessels Due: Week 6 Lec 11
Page 1 Homework 11 Chapter 18-19 Blood Vessels Due: Week 6 Lec 11 Contents When printing, make sure that you specify the page range that you want to print out! Learning objectives for Lecture 11:...pg
More informationNOTES: CH 44 Regulating the Internal Environment (Homeostasis & The Urinary System)
NOTES: CH 44 Regulating the Internal Environment (Homeostasis & The Urinary System) HOMEOSTASIS **Recall HOMEOSTASIS is the steady-state physiological condition of the body. It includes: 1) Thermoregulation:
More informationGlomerular Capillary Blood Pressure
Glomerular Capillary Blood Pressure Fluid pressure exerted by blood within glomerular capillaries Depends on Contraction of the heart Resistance to blood flow offered by afferent and efferent arterioles
More informationCOMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan
Rotazar (Film coated tablets) Irbesartan Rotazar 75 mg, 150 mg, 300 mg COMPOSITION A film coated tablet contains Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar 75 mg, 150 mg, 300 mg PHARMACOLOGICAL
More informationClass XI Chapter 19 Excretory Products and their Elimination Biology
Class XI Chapter 19 Excretory Products and their Elimination Biology Question 1: Define Glomerular Filtration Rate (GFR) Glomerular filtration rate is the amount of glomerular filtrate formed in all the
More informationSeptic Acute Kidney Injury (AKI) Rinaldo Bellomo Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) Melbourne Australia
Septic Acute Kidney Injury (AKI) Rinaldo Bellomo Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) Melbourne Australia Things we really, honestly know about septic AKI AKI is common
More informationCRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT
CRRT Fundamentals Pre-Test AKI & CRRT 2017 Practice Based Learning in CRRT Question 1 A 72-year-old man with HTN presents to the ED with slurred speech, headache and weakness after falling at home. He
More information014 Chapter 14 Created: 9:25:14 PM CST
014 Chapter 14 Created: 9:25:14 PM CST Student: 1. Functions of the kidneys include A. the regulation of body salt and water balance. B. hydrogen ion homeostasis. C. the regulation of blood glucose concentration.
More informationOutline Urinary System. Urinary System and Excretion. Urine. Urinary System. I. Function II. Organs of the urinary system
Outline Urinary System Urinary System and Excretion Bio105 Chapter 16 Renal will be on the Final only. I. Function II. Organs of the urinary system A. Kidneys 1. Function 2. Structure III. Disorders of
More informationHuman Creatinine Urinary Detection Kit
Human Creatinine Urinary CATALOG NO: IRAAKT2509 Detection Kit LOT NO: SAMPLE INTENDED USE The Urinary Creatinine kit is designed to quantitatively measure creatinine present in urine samples. BACKGROUND
More information